DUROLANE®

Product Information

• Active ingredient: Sodium hyaluronate (NASHA, non-animal stabilized hyaluronic acid)
• Strength: 20 mg/ml (60 mg/3 ml)
• Package content: 1 x 3 ml pre-filled syringe
• Manufacturer: Q-Med
• Brand: DUROLANE®
• Category: Orthopedic Injections

DUROLANE® Dosage and Administration

DUROLANE® is supplied as follows:

• A single-use, pre-filled syringe containing 60 mg/3 ml of stabilized hyaluronic acid.

Administration guidelines include:

• Administer via intra-articular injection directly into the affected joint.
• Single injection per treatment session.
• The procedure must be performed by healthcare professionals experienced in joint injections.
• Aseptic technique and standard clinical protocols should be strictly followed during administration.

Ingredient Information

DUROLANE® contains:

• Stabilized hyaluronic acid (60 mg/3 ml), non-animal derived, ensuring biocompatibility and safety.
• Phosphate-buffered saline to maintain product stability and physiological compatibility.

This formulation delivers extended lubrication and effective joint cushioning.

Storage Instructions

• Store between 2°C and 25°C.
• Protect from direct sunlight, moisture, and freezing.
• Keep sealed in the original packaging until ready for use.
• Do not use beyond expiration date or if the packaging integrity is compromised.

Proper storage of orthopedic injections helps maintain the quality, efficacy, and safety of DUROLANE®.

DUROLANE® Contraindications

Avoid using DUROLANE® in patients who:

• Are pregnant or breastfeeding.
• Exhibit known hypersensitivity to hyaluronic acid or other components.
• Have active joint infections or skin lesions at the injection site.
• Are experiencing severe inflammation or autoimmune joint conditions without prior medical consultation.

DUROLANE® Precautions and Warnings

• Administer exclusively in sterile clinical settings by experienced medical professionals.
• Conduct thorough patient evaluations, including allergy assessments, medical history, and current medications.
• Avoid injection into blood vessels and surrounding tissues to prevent complications.
• Clearly instruct patients on post-treatment care, including activities to avoid and signs of potential adverse reactions.

DUROLANE® Manufacturer and Regulatory Information

DUROLANE® is manufactured by Q-Med, the Swedish company behind NASHA (non-animal stabilized hyaluronic acid) technology, and marketed internationally by Bioventus, a healthcare company specializing in orthopedics and osteoarthritis management.

• Supplied for professional use in accordance with applicable regulations.
• Produced under rigorous quality control processes.
• Trusted globally by healthcare providers for safety, consistency, and effectiveness.

Healthcare providers who choose to order DUROLANE® or purchase DUROLANE products from Kinami Health benefit from authentic products, assured clinical efficacy, and comprehensive support to optimize patient outcomes.

Buying DUROLANE® in Canada

Kinami Health supplies genuine DUROLANE® to licensed healthcare professionals and clinics across Canada, sourced through verified channels and delivered in sealed original packaging with a traceable LOT number, with wholesale pricing and fast delivery.

In Canada, who may administer intra-articular injections varies by province and professional college; practitioners should follow the rules that apply in their own jurisdiction. Adverse reactions can be reported to Health Canada.

Explore the full DUROLANE® range or compare other products in the Orthopedic Injections category.